Discrepancies between ALK protein disruption and occurrence of ALK gene rearrangement in Polish NSCLC patients

BACKGROUND: Non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations or anaplastic lymphoma kinase (ALK) rearrangement are predisposed to molecularly targeted therapies. Proper diagnostic is crucial for quick and correct patients qualification to optimal tre...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Thorac Dis
Autors principals: Grenda, Anna, Jarosz, Bożena, Krawczyk, Paweł, Kucharczyk, Tomasz, Wojas-Krawczyk, Kamila, Reszka, Katarzyna, Krukowska, Kinga, Nicoś, Marcin, Pankowski, Juliusz, Bryl, Maciej, Ramlau, Rodryg, Kuźnar-Kamińska, Barbara, Grodzki, Tomasz, Szczęsna, Aleksandra, Siemiątkowska, Krystyna, Szumiło, Justyna, Batura-Gabryel, Halina, Palonka, Michał, Milanowski, Janusz
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6129873/
https://ncbi.nlm.nih.gov/pubmed/30233874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.07.28
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars